Ajanta Pharma Q1 Profit Up 18% to Rs 246 Cr - Business News
Jul 30, 2024 16:53
Ajanta Pharma's net profit surged 18% to Rs 246 crore in Q1 FY24, driven by strong sales in India and overseas markets. Revenue also climbed.
New Delhi, Jul 30 (PTI) Ajanta Pharma on Tuesday said its consolidated profit after tax (PAT) increased 18 per cent year-on-year to Rs 246 crore for the June quarter, on account of robust sales across domestic and international markets.
The drug firm had reported a profit after tax of Rs 208 crore in the April-June quarter of last fiscal.
Revenue from operations rose to Rs 1,145 crore during the quarter under review as against Rs 1,021 crore in the year-go period, Ajanta Pharma said in a regulatory filing.
The company said its India sales grew 10 per cent year-on-year to Rs 353 crore in the first quarter.
The company's US sales grew 7 per cent to Rs 228 crore in the first quarter of the current fiscal.
Shares of Ajanta Pharma ended 3.99 per cent up at Rs 2,524.35 apiece on the BSE.
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.